
### [NCIT:C27260](http://purl.obolibrary.org/obo/NCIT_C27260)
**Label:** Dendritic Cell Tumor, Not Otherwise Specified

**Subclasses:** 

**Class expressions from DL-Learner:**

- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 57.14%
- [NCIT:C43268](http://purl.obolibrary.org/obo/NCIT_C43268) (HMB-45-Positive Neoplastic Cells Present) 53.57%
- [NCIT:C43267](http://purl.obolibrary.org/obo/NCIT_C43267) (CD1a-Positive Neoplastic Cells Present) 53.57%
- [NCIT:C43266](http://purl.obolibrary.org/obo/NCIT_C43266) (Birbeck Granules Present) 53.57%
- [NCIT:C43251](http://purl.obolibrary.org/obo/NCIT_C43251) (Histiocytic and Dendritic Cell) 53.57%
- [NCIT:C40995](http://purl.obolibrary.org/obo/NCIT_C40995) (CD68-Positive Neoplastic Cells Present) 53.57%
- [NCIT:C40993](http://purl.obolibrary.org/obo/NCIT_C40993) (S-100-Positive Neoplastic Cells Present) 53.57%
- [NCIT:C39715](http://purl.obolibrary.org/obo/NCIT_C39715) (CD30-Positive Neoplastic Cells Present) 53.57%
- Thing 53.00%
- [NCIT:C40998](http://purl.obolibrary.org/obo/NCIT_C40998) (Positive Immunophenotypic Test Result) 39.78%
- [NCIT:C36446](http://purl.obolibrary.org/obo/NCIT_C36446) (Clonal T-Cell Receptor Gene Rearrangement) and (not ([NCIT:C36448](http://purl.obolibrary.org/obo/NCIT_C36448) (Clonal T-Cell Receptor Gamma Chain Gene Rearrangement))) 38.93%
- [NCIT:C36446](http://purl.obolibrary.org/obo/NCIT_C36446) (Clonal T-Cell Receptor Gene Rearrangement) and (not ([NCIT:C36447](http://purl.obolibrary.org/obo/NCIT_C36447) (Clonal T-Cell Receptor Beta Chain Gene Rearrangement))) 38.93%
- [NCIT:C35682](http://purl.obolibrary.org/obo/NCIT_C35682) (Positive Laboratory Test Result) 37.94%
- [NCIT:C36446](http://purl.obolibrary.org/obo/NCIT_C36446) (Clonal T-Cell Receptor Gene Rearrangement) 32.44%
- [NCIT:C36446](http://purl.obolibrary.org/obo/NCIT_C36446) (Clonal T-Cell Receptor Gene Rearrangement) and (not ([NCIT:C39897](http://purl.obolibrary.org/obo/NCIT_C39897) (Prostate Ductal Adenocarcinoma, Solid Pattern))) 32.44%


